ESPERITE 2,154,000 shares exchanged today. Thank you for your interest in our company FR

February 25, 2015 Group News FR

FR ESPERITE (ESP) 2’154’000 shares EXCHANGED TODAY.  THE COMPANY publishes this note of appreciation addressed to all the investors who massively increased the volume of transactions at the Euronext stock exchange today.

Frederic Amar, CEO of ESPERITE: “We are enthusiastic to notice this huge interest in our company. I would like to thank personally all the investors who made this day so unique.”

Geneva, Switzerland

read more

ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells FR

February 23, 2015 Group News FR

FR CryoSave, part of ESPERITE, is the only private cord blood bank sponsoring a GCP clinical trial according to GMP-ATMP international guidelines

CryoSave leads and sponsors a multicentre clinical trial following GCP-ICH standards, for investigation of new treatment of Cerebral Palsy using dual infusion of two types of stem cells derived from umbilical cord blood and cord tissue processed by CryoSave

Geneva, Switzerland

read more